Steven M. Kwasny

890 total citations
17 papers, 685 citations indexed

About

Steven M. Kwasny is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Steven M. Kwasny has authored 17 papers receiving a total of 685 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Infectious Diseases. Recurrent topics in Steven M. Kwasny's work include Antibiotic Resistance in Bacteria (4 papers), Antimicrobial Peptides and Activities (4 papers) and Biochemical and Structural Characterization (3 papers). Steven M. Kwasny is often cited by papers focused on Antibiotic Resistance in Bacteria (4 papers), Antimicrobial Peptides and Activities (4 papers) and Biochemical and Structural Characterization (3 papers). Steven M. Kwasny collaborates with scholars based in United States, Czechia and Italy. Steven M. Kwasny's co-authors include Timothy J. Opperman, Terry L. Bowlin, Son T. Nguyen, Hiroshi Nikaido, Hong‐Suk Kim, Norton P. Peet, Xiaoyuan Ding, John D. Williams, Sanjay D’Souza and Graham C. Walker and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and PLoS ONE.

In The Last Decade

Steven M. Kwasny

16 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Steven M. Kwasny United States	10	330	312	144	120	98	17	685
Timothy R. Kane Canada	5	287 0.9×	255 0.8×	88 0.6×	165 1.4×	83 0.8×	5	797
Shannon B. Falconer Canada	8	343 1.0×	269 0.9×	77 0.5×	138 1.1×	131 1.3×	9	703
Frédéric Collin United Kingdom	7	475 1.4×	147 0.5×	186 1.3×	98 0.8×	94 1.0×	9	705
Ryuta Kishii United States	13	267 0.8×	236 0.8×	132 0.9×	224 1.9×	85 0.9×	17	611
Silvia D’Arezzo Italy	20	338 1.0×	581 1.9×	94 0.7×	185 1.5×	110 1.1×	37	1.0k
Atin Sharma India	9	243 0.7×	311 1.0×	64 0.4×	96 0.8×	70 0.7×	13	589
Xuan Wang‐Kan United Kingdom	7	382 1.2×	518 1.7×	54 0.4×	145 1.2×	115 1.2×	7	930
Evan Martens United States	7	297 0.9×	173 0.6×	146 1.0×	182 1.5×	83 0.8×	8	730
Inga V. Leus United States	14	238 0.7×	457 1.5×	49 0.3×	165 1.4×	58 0.6×	28	649

Countries citing papers authored by Steven M. Kwasny

Since Specialization

Citations

This map shows the geographic impact of Steven M. Kwasny's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven M. Kwasny with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven M. Kwasny more than expected).

Fields of papers citing papers by Steven M. Kwasny

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven M. Kwasny. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven M. Kwasny. The network helps show where Steven M. Kwasny may publish in the future.

Co-authorship network of co-authors of Steven M. Kwasny

This figure shows the co-authorship network connecting the top 25 collaborators of Steven M. Kwasny. A scholar is included among the top collaborators of Steven M. Kwasny based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Steven M. Kwasny. Steven M. Kwasny is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Gardner, Thomas J., Steven M. Kwasny, Steven C. Cardinale, et al.. (2022). Investigating N-arylpyrimidinamine (NAPA) compounds as early-stage inhibitors against human cytomegalovirus. Antiviral Research. 209. 105474–105474. 3 indexed citations

Butler, Michelle M., Samanthi L. Waidyarachchi, Son T. Nguyen, et al.. (2022). Optimized Pyridazinone Nutrient Channel Inhibitors Are Potent and Specific Antimalarial Leads. Molecular Pharmacology. 102(3). 172–182. 5 indexed citations

Aron, Zachary D., Eric D. Hoffer, Kristie L. Connolly, et al.. (2021). trans-Translation inhibitors bind to a novel site on the ribosome and clear Neisseria gonorrhoeae in vivo. Nature Communications. 12(1). 1799–1799. 29 indexed citations

Chauhan, Jay, et al.. (2019). Optimization of a small-molecule Lipid II binder. Bioorganic & Medicinal Chemistry Letters. 29(14). 1849–1853.

Lee, Sung Hyen, et al.. (2018). Pleiotropic Anti-Infective Effects of Defensin-Derived Antimicrobial Compounds. Avian Diseases. 62(4). 381–381. 2 indexed citations

Sjuts, Hanno, Attilio V. Vargiu, Steven M. Kwasny, et al.. (2016). Molecular basis for inhibition of AcrB multidrug efflux pump by novel and powerful pyranopyridine derivatives. Proceedings of the National Academy of Sciences. 113(13). 3509–3514. 161 indexed citations

Cardinale, Steven C., Lei Fang, Jing Huang, et al.. (2016). Towards Development of Small Molecule Lipid II Inhibitors as Novel Antibiotics. PLoS ONE. 11(10). e0164515–e0164515. 6 indexed citations

Opperman, Timothy J., Steven M. Kwasny, Mark A. Lewis, et al.. (2016). DNA Targeting as a Likely Mechanism Underlying the Antibacterial Activity of Synthetic Bis-Indole Antibiotics. Antimicrobial Agents and Chemotherapy. 60(12). 7067–7076. 21 indexed citations

Nguyen, Son T., Steven M. Kwasny, Xiaoyuan Ding, et al.. (2015). Structure–activity relationships of a novel pyranopyridine series of Gram-negative bacterial efflux pump inhibitors. Bioorganic & Medicinal Chemistry. 23(9). 2024–2034. 65 indexed citations

10.

Leeuw, Erik de, Steven Fletcher, Wenbo Yu, et al.. (2015). Structure–activity exploration of a small-molecule Lipid II inhibitor. Drug Design Development and Therapy. 9. 2383–2383. 9 indexed citations

11.

Nguyen, Son T., Steven M. Kwasny, Xiaoyuan Ding, et al.. (2015). Synthesis and antifungal evaluation of head-to-head and head-to-tail bisamidine compounds. Bioorganic & Medicinal Chemistry. 23(17). 5789–5798. 22 indexed citations

12.

Wallace, Joselynn, Debra M. Mills, Panatda Saenkham, et al.. (2015). Discovery of Bacterial Fatty Acid Synthase Type II Inhibitors Using a Novel Cellular Bioluminescent Reporter Assay. Antimicrobial Agents and Chemotherapy. 59(9). 5775–5787. 14 indexed citations

13.

Rasapalli, Sivappa, Christiaan A. Rees, James A. Golen, et al.. (2013). Detour of prenostodione synthesis towards pyrazolones for antibacterial activity. Bioorganic & Medicinal Chemistry Letters. 23(11). 3235–3238. 17 indexed citations

14.

Opperman, Timothy J., Steven M. Kwasny, Hong‐Suk Kim, et al.. (2013). Characterization of a Novel Pyranopyridine Inhibitor of the AcrAB Efflux Pump of Escherichia coli. Antimicrobial Agents and Chemotherapy. 58(2). 722–733. 154 indexed citations

15.

Rasapalli, Sivappa, Christiaan A. Rees, James A. Golen, et al.. (2013). Design, synthesis and activities of 4/5-acyl-2-aminoimidazolyl analogues of oroidin for biofilm inhibition. MedChemComm. 4(11). 1467–1467. 4 indexed citations

16.

Kwasny, Steven M. & Timothy J. Opperman. (2010). Static Biofilm Cultures of Gram‐Positive Pathogens Grown in a Microtiter Format Used for Anti‐Biofilm Drug Discovery. Current Protocols in Pharmacology. 50(1). Unit 13A.8–Unit 13A.8. 127 indexed citations

17.

Kwasny, Steven M., John D. Williams, Atiyya R. Khan, et al.. (2009). Aryl Rhodanines Specifically Inhibit Staphylococcal and Enterococcal Biofilm Formation. Antimicrobial Agents and Chemotherapy. 53(10). 4357–4367. 46 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact